תוצאות חיפוש - Gregory D. Busse
- Showing 1 - 3 results of 3
-
1
A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hypera... מאת Azmi Nasser, Tesfaye Liranso, Toyin Adewole, Nicholas Fry, Joseph T. Hull, Fatima Chowdhry, Gregory D. Busse, Andrew J. Cutler, Nandita Joshi Jones, Robert L. Findling, Stefan Schwabe
יצא לאור 2020Artigo -
2
A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder מאת Azmi Nasser, Tesfaye Liranso, Toyin Adewole, Nicholas Fry, Joseph T. Hull, Gregory D. Busse, Fatima Chowdhry, Andrew J. Cutler, Nandita Joshi Jones, Robert L. Findling, Stefan Schwabe
יצא לאור 2021Artigo -
3
Effects of ganaxolone on non-seizure outcomes in CDKL5 Deficiency Disorder: Double-blind placebo-controlled randomized trial מאת Jenny Downs, Peter Jacoby, Nicola Specchio, H Cross, S Amin, Nadia Bahi‐Buisson, Rajsekar R. Rajaraman, Bernhard Suter, Orrin Devinsky, A Aimetti, Gregory D. Busse, Heather E. Olson, S Demarest, T A Benke, E Pestana-Knight
יצא לאור 2024Artigo
כלי חיפוש:
נושאים קשורים
Alternative medicine
Medicine
Pathology
Placebo
Psychiatry
Attention deficit hyperactivity disorder
Internal medicine
Pediatrics
Randomized controlled trial
Adverse effect
Anesthesia
Chemistry
Clinical Global Impression
Clinical endpoint
Clinical trial
Developmental psychology
Double blind
Epilepsy
Immediate release
Organic chemistry
Pharmacology
Phase (matter)
Physical therapy
Psychology
Randomization
Rating scale
Seizure Disorders